Search Results - "ten Seldam, Silene"

Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study by Cohen, Adam D., Hari, Parameswaran, Htut, Myo, Berdeja, Jesus G., Usmani, Saad Z., Madduri, Deepu, Olyslager, Yunsi, Goldberg, Jenna D., Schecter, Jordan M., Jackson, Carolyn C., Gries, Katharine S., Fastenau, John M., Valluri, Satish, Deraedt, William, Akram, Muhammad, Crawford, Rebecca, Morrison, Ross, Doward, Lynda, Morgan, Kate, Seldam, Silene ten, Jakubowiak, Andrzej, Jagannath, Sundar

“…Ciltacabtagene autoleucel (cilta-cel), a novel chimeric antigen receptor T (CAR-T) cell therapy, has demonstrated early, deep, and durable clinical responses…”
Get full text

PB2679: MIXED‐METHOD, CROSS‐SECTIONAL SURVEY TO DESCRIBE FEELINGS, PERCEPTION, AND EXPERIENCE OF MULTIPLE MYELOMA PATIENTS WHO SWITCHED FROM INTRAVENOUS DARATUMUMAB TO THE SUBCUTANEOUS FORMULATION IN EUROPE by Magarotto, Valeria, Thevenon, Julien, Morgan, Kate, Seldam, Silene Ten, Iraqi, Wafae, Guillaume, Xavier, Horchi, Dahbia, Rault, Bleuenn, Gruppe, Traugott Ludwig

Get full text

P-086 Patient and haematologist perspectives of minimal residual disease testing in myeloma by Seldam, Silene ten, Morgan, Kate, Joyner, Katie

Get full text

P-117 How Do Patients Feel About How, When and Where They Get Their Treatments? A European Survey of Myeloma Patients by Duncan, Eilidh, Seldam, Silene ten, Joyner, Katie, Morgan, Kate

Get full text

Differences in emotional contagion, interpersonal relationships and social rewards in males and females: examining the links with primary and secondary psychopathic traits by Kyranides, Melina Nicole, Lu, Kiara Margarita, Ten Seldam, Silene

“…Individuals with psychopathic traits display low empathy and as a result they have difficulties maintaining meaningful relationships. Emotional contagion, the…”
Get full text

Health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) receiving real-life current standard of care (SOC) in the LocoMMotion study by Delforge, Michel, Moreau, Philippe, Einsele, Hermann, De Stefano, Valerio, Lindsey-Hill, Joanne, Vincent, Laure, Mangiacavalli, Silvia, Perrot, Aurore, Ocio, Enrique, ten Seldam, Silene, in ’t Groen-Damen, Ester, Semerjian, Maria, Strulev, Vadim, Schecter, Jordan Mark, Roccia, Tito, Gries, Katharine S., Nesheiwat, Tonia, Wapenaar, Robert, Mateos, Maria-Victoria, Weisel, Katja

“…8030 Background: Evaluation of patient (pt)-reported outcomes provides insight into how real-life SOC treatments (tx) affect HRQoL for pts with RRMM…”
Get full text

Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practice by Liu, Limin, Choi, Jungyeon, Musoro, Jammbe Z, Sauerbrei, Willi, Amdal, Cecilie Delphin, Alanya, Ahu, Barbachano, Yolanda, Cappelleri, Joseph C, Falk, Ragnhild Sørum, Fiero, Mallorie H, Regnault, Antoine, Reijneveld, Jaap C, Sandin, Rickard, Thomassen, Doranne, Roychoudhury, Satrajit, Goetghebeur, Els, le Cessie, Saskia, Aiyegbusi, Olalekan Lee, Alanya, Ahu, Barbachano, Yolanda, Basch, Ethan, Calvert, Melanie, Campbell, Alicyn, Cappelleri, Joseph, Choi, Jungyeon, Cruz Rivera, Samantha, Delphin Amdal, Cecilie, Fiero, Mallorie, Goetghebeur, Els, Kamalakar, Rajesh, Keating, Karen, Kluetz, Paul, le Cessie, Saskia, Liu, Limin, Molenberghs, Geert, Musoro, Jammbe, Ness, David, Rantell, Khadija, Regnault, Antoine, Reijneveld, Jaap, Roychoudhury, Satrajit, Rumpold, Gerhard, Russell-Smith, Alexander, Rutherford, Claudia, Sail, Kavita, Sandin, Rickard, Sasseville, Maxime, Sauerbrei, Willi, Schiel, Anja, Schlichting, Michael, Soltys, Kathy, Sorum Falk, Ragnhild, Su, Yun, ten Seldam, Silene, Thomassen, Doranne, Van Lancker, Kelly

“…Patient-reported outcomes (PROs) are increasingly used in single-arm cancer studies. We reviewed 60 papers published between 2018 and 2021 of single-arm…”
Get full text

Description of Feelings, Perception, and Experience Before and After Switching from IV Daratumumab to the SC Form: A Mixed-Method, Cross-Sectional Survey in Multiple Myeloma Patients in Europe by Magarotto, Valeria, Thevenon, Julien, Morgan, Kate, Ten Seldam, Silene, Iraqi, Wafae, Guillaume, Xavier, Leclerc, Marjorie, Graziani-Taugeron, Claire, Rault, Bleuenn, Horchi, Dahbia

“…To provide real-world data on patient perceptions and experiences with subcutaneous (SC) versus intravenous (IV) daratumumab. This was a cross-sectional,…”
Get full text

P-239: Health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) receiving real-life standard of care (SOC) treatments: results from the LocoMMotion study by Delforge, Michel, Moreau, Philippe, Einsele, Hermann, De Stefano, Valerio, Lindsey-Hill, Joanne, Vincent, Laure, Mangiacavalli, Silvia, Perrot, Aurore, Ocio, Enrique, ten Seldam, Silene, Groen-Damen, Ester in ’t, Semerjian, Maria, Strulev, Vadim, Schecter, Jordan, Roccia, Tito, Gries, Katharine, Nesheiwat, Tonia, Wapenaar, Robert, Mateos, María-Victoria, Weisel, Katja

Get full text